Rol de los inflamasomas en pacientes con hipertensión resistenteen los pacientes derivados de hospitales de la Provincia de Mendoza
Ischemic heart disease (CHD) remains one of the main causes of global mortality despite the evidence-based therapies obtained from clinical trials. Although significant resources are allocated to develop newer treatments, resistant hypertension (HTR) and lack of adherence to medications prevent achi...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://bdigital.uncu.edu.ar/fichas.php?idobjeto=14752 |
